These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31939390)

  • 81. Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets.
    Keklik M; Keklik E; Korkmaz S; Aygun B; Arik F; Kilic O; Sarikoc M
    Transfus Apher Sci; 2015 Dec; 53(3):396-8. PubMed ID: 26283175
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
    DAS SS; Chaudhary RK; Shukla JS
    Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Decreased levels of ferritin, mild thrombocytosis, and increased erythropoietin are sequential events among frequent plateletpheresis donors: Implication for a ferritin screen.
    Chin LT; Woon JY; Kuo SW; Lu SC
    Transfus Apher Sci; 2022 Dec; 61(6):103501. PubMed ID: 35835689
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Feasibility of high-yield plateletpheresis in routine practice: Experience from tertiary health center from South India.
    Sahoo D; Noushad S; Basavarajegowda A; Toora E
    Asian J Transfus Sci; 2023; 17(1):34-40. PubMed ID: 37188018
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative study.
    Kaufman RM; Marks DC; Flamand Y; Acker JP; Brown BL; Olafson C; Marschner S; Pandey S; Papari M; Petraszko T; Serrano K; Ward D; Bazin R;
    Transfusion; 2023 Nov; 63(11):2072-2082. PubMed ID: 37818894
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Changes in Hematological Indices and Lymphocyte Subsets in Response to Platelet Apheresis Donation.
    Borai A; Bahijri S; Almohammadi M; Al-Sofyani A; Baljoon D; Al-Amri A; Boraie S; Ferns G
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013347
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
    Fontana S; Rados L; Schmid P; Leibundgut EO; Taleghani BM
    Transfusion; 2011 Sep; 51(9):2034-43. PubMed ID: 21438883
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A statistical model for estimating donor postdonation platelet counts after plateletpheresis.
    Cabezudo I; Winegarden DK; Randels MJ; Strauss RG
    Transfusion; 1994 Jan; 34(1):54-7. PubMed ID: 8273130
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120.
    Ifran A; Haşimi A; Kaptan K; Nevruz O; Beyan C; Erbil K
    Transfus Apher Sci; 2005 Oct; 33(2):87-90. PubMed ID: 16139569
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Improvement of plateletpheresis via technical modification on the MCS+.
    Zhou Q; Yu X; Liu L; Cai Y
    Transfus Med; 2015 Jun; 25(3):184-8. PubMed ID: 26074299
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Haemostatic parameters, platelet activation markers, and platelet indices among regular plateletpheresis donors.
    Tuan HTM; Hock LS; Abdullah ZW
    J Taibah Univ Med Sci; 2018 Apr; 13(2):180-187. PubMed ID: 31435321
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial.
    Heuft HG; Moog R; Fischer EG; Zingsem J;
    Transfusion; 2013 Jan; 53(1):211-20. PubMed ID: 22612302
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Plateletpheresis efficiency and mathematical correction of software-derived platelet yield prediction: A linear regression and ROC modeling approach.
    Jaime-Pérez JC; Jiménez-Castillo RA; Vázquez-Hernández KE; Salazar-Riojas R; Méndez-Ramírez N; Gómez-Almaguer D
    J Clin Apher; 2017 Oct; 32(5):329-334. PubMed ID: 27862253
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effective cell support by repeat plateletpheresis of related donors on the IBM 2997 cell separator.
    Langley JW; Spiva D; Hendren D; Orrell J
    Am J Clin Pathol; 1981 Aug; 76(2):148-54. PubMed ID: 7270495
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Endogenous serum levels of thrombopoietic cytokines in healthy whole-blood and platelet donors: implications for plateletpheresis.
    Tacke F; Schöffski P; Trautwein C; Martin MU; Stangel W; Seifried E; Manns MP; Ganser A; Petersen D
    Br J Haematol; 1999 May; 105(2):511-3. PubMed ID: 10233430
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Automated plateletpheresis does not cause an increase in platelet activation in volunteer donors.
    Karadoğan I; Undar L
    Ther Apher; 1997 May; 1(2):174-7. PubMed ID: 10225766
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Serum ferritin in plateletpheresis and whole blood donors.
    Duggan F; O'Sullivan K; Power JP; Healy M; Murphy WG
    Transfus Apher Sci; 2016 Aug; 55(1):159-63. PubMed ID: 27339300
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of plateletpheresis on total platelet count and mean platelet volume: A meta-analysis.
    Gil-Betancur A; Mantilla-Gutierrez CY; Cardona-Arias JA
    J Evid Based Med; 2020 Aug; 13(3):206-214. PubMed ID: 32615026
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India.
    Ojha S; Gupta AM; Nagaraju P; Poojary M; S H S
    Transfus Apher Sci; 2020 Oct; 59(5):102868. PubMed ID: 32646793
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The selection of donors in multicomponent collection management.
    Bonomo P; Garozzo G; Bennardello F
    Transfus Apher Sci; 2004 Feb; 30(1):55-9. PubMed ID: 14746822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.